These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3095605)

  • 21. The association of cyclosporine with the 1-year costs of cadaver-donor kidney transplants.
    Showstack J; Katz P; Amend W; Salvatierra O
    JAMA; 1990 Oct; 264(14):1818-23. PubMed ID: 2402040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring kidney dialysis costs in the United States: a scoping review.
    Stewart F; Kistler K; Du Y; Singh RR; Dean BB; Kong SX
    J Med Econ; 2024; 27(1):618-625. PubMed ID: 38605648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis.
    Naci H; de Lissovoy G; Hollenbeak C; Custer B; Hofmann A; McClellan W; Gitlin M
    J Med Econ; 2012; 15(2):293-304. PubMed ID: 22115328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy.
    Baltzan MA; Ahmed S; Baltzan RB; Marshall RP; Thoma EL; Nicol MF
    Clin Nephrol; 1997 Jun; 47(6):351-5. PubMed ID: 9202863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of Medicare's coverage of immunosuppression medications for kidney transplant recipients.
    Page TF; Woodward RS
    Expert Rev Pharmacoecon Outcomes Res; 2009 Oct; 9(5):435-44. PubMed ID: 19817527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The economic implications of HLA matching in cadaveric renal transplantation.
    Schnitzler MA; Hollenbeak CS; Cohen DS; Woodward RS; Lowell JA; Singer GG; Tesi RJ; Howard TK; Mohanakumar T; Brennan DC
    N Engl J Med; 1999 Nov; 341(19):1440-6. PubMed ID: 10547408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Why are cadaveric renal transplants so hard to find in Japan? An analysis of economic and attitudinal aspects.
    Ohi G; Hasegawa T; Kumano H; Kai I; Takenaga N; Taguchi Y; Saito H; Ino T
    Health Policy; 1986; 6(3):269-78. PubMed ID: 10311723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The financial implications for Medicare of greater use of peritoneal dialysis.
    Neil N; Guest S; Wong L; Inglese G; Bhattacharyya SK; Gehr T; Walker DR; Golper T
    Clin Ther; 2009 Apr; 31(4):880-8. PubMed ID: 19446160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of repeat medical procedures: kidney transplantation as an example.
    Hornberger JC; Best JH; Garrison LP
    Med Decis Making; 1997; 17(4):363-72. PubMed ID: 9343794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomised comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function.
    Henny FC; Kootte AM; Van Bockel JH; Baldwin WM; Hermans J; Bos B; van Es LA; Paul LC
    Nephrol Dial Transplant; 1986; 1(1):44-9. PubMed ID: 3110662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs.
    Gjertson DW; Terasaki PI; Takemoto S; Mickey MR
    N Engl J Med; 1991 Apr; 324(15):1032-6. PubMed ID: 2005940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of treatment costs between dialysis and transplantation.
    Eggers P
    Semin Nephrol; 1992 May; 12(3):284-9. PubMed ID: 1615249
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients: a Canadian payer perspective.
    Vegter S; Tolley K; Keith MS; Lok CE; Soroka SD; Morton AR
    Clin Ther; 2012 Jul; 34(7):1531-43. PubMed ID: 22742885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost analysis of the Hemodialysis Reliable Outflow (HeRO) Graft compared to the tunneled dialysis catheter.
    Al Shakarchi J; Inston N; Jones RG; Maclaine G; Hollinworth D
    J Vasc Surg; 2016 Apr; 63(4):1026-33. PubMed ID: 26826055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economics of kidney transplantation versus hemodialysis.
    Loubeau PR; Loubeau JM; Jantzen R
    Prog Transplant; 2001 Dec; 11(4):291-7. PubMed ID: 11871278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
    Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.